Third, initial efforts to treat chronic lymphocytic leukemia (CLL) (by also targeting CD19) were somewhat disappointing,4,5 leading to a shift towards investigations in pediatric B-ALL (as well as towards adult diffuse large B-cell lymphoma; DLBCL). The gene discussed is CD19; the disease is B-cell chronic lymphocytic leukemia.